PURPOSE: To assess the effects of standardized garlic powder tablets o
n serum lipids and lipoproteins, glucose, and blood pressure. SUBJECTS
AND METHODS: Forty-two healthy adults (19 men, 23 women), mean age of
52 +/- 12 years, with a serum total cholesterol (TC) level of greater
than or equal to 220 mg/dL received, in a randomized, double-blind fa
shion, either:300 mg three times a day of standardized garlic pow der
in tablet form or placebo. Diets and physical activity were unchanged
This study was conducted in an outpatient, clinical research unit. RES
ULTS: The baseline serum TC level of 262 +/- 34 mg/dL was reduced to 2
47 +/- 40 mg/dL (p <0.01) after 12 weeks of standard garlic treatment.
Corresponding values for placebo were 276 +/- 34 mg/dL before and 274
+/- 29 mg/dL, after placebo treatment. Low-density lipoprotein choles
terol (LDL-C) was reduced by 11% by garlic treatment and 3% by placebo
(p <0.05). There were no significant changes in high-density lipoprot
ein cholesterol, triglycerides, serum glucose, blood pressure, and oth
er monitored parameters CONCLUSIONS: Treatment with standardized garli
c 900 mg/d produced a significantly greater reduction in serum TC and
LDL-C than placebo. The garlic formulation was well tolerated without
any odor problems.